Fresh analysis indicates that individuals who discontinue new slimming jabs like Wegovy and Mounjaro can put back on reduced body mass much more quickly than those who end conventional diet and exercise regimens.
Published data in a prominent health publication points out that while overweight people frequently drop substantial amounts of their body weight while on the medication, the weight is regained at an estimated rate of nearly a kilo each month once they quit.
"Users using such drugs must be cognizant of the risk of quick rebound weight gain when the treatment is stopped," stated researcher Dr. Susan Jebb.
That rate of regain means a reversion to original weight in about a year and a half.
Analyzing Approaches
The study, which examined 37 of studies involving over 9,000 of participants, contrasted the results of GLP-1 agonists with other pills.
Researchers emphasize that individuals who lose weight through diet and exercise usually experience a slower creep back—around 100 grams monthly—post-intervention.
Understanding the Fast Rebound
Experts believe the mode of action of the jabs accounts for the accelerated weight return.
The injections imitate a natural hormone called glucagon-like peptide-1, which helps regulate appetite.
"Artificially providing the hormone concentrations several times higher than normal might result in the body to generate a reduced amount of its endogenous hormone, and could lessen responsiveness to its actions," explained Dr. Adam Collins, a nutrition expert.
"Withdrawal of this GLP-1 'fix' means appetite is uncontrolled, making overeating a significant risk."
A Lifelong Disease?
Health authorities suggest the jabs for people with obesity-related health risks, accompanied by recommended lifestyle changes.
Many experts say that, considering the significant potential of relapse, the therapy might need to be life-long.
This opinion is echoed by drug manufacturers, who note that the results "emphasize the chronic nature of obesity," comparing it to managing diseases like diabetes.
User Testimonies
Individuals who have discontinued the jabs describe a sudden resurgence of cravings.
"I experienced something activating and you're instantly ravenous," recalled one woman.
The struggle is worsened if patients have not developed permanent dietary or behavioural changes during treatment.
Widespread Use
Survey data indicate that a significant number of adults in the UK have used these injections in the last 12 months, with demand continuing to grow.
- Use is higher among women than males.
- The 40s and 50s demographic shows the greatest level of interest.
- A large proportion access the medications through private prescriptions rather than the NHS.
Ultimately, clinicians emphasize that while these medications are potent agents for weight loss, they are not a magic fix and long-term success relies on combined lifestyle changes.
